0001179110-15-013306.txt : 20150911
0001179110-15-013306.hdr.sgml : 20150911
20150911172815
ACCESSION NUMBER: 0001179110-15-013306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150909
FILED AS OF DATE: 20150911
DATE AS OF CHANGE: 20150911
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDFISCHER CARL
CENTRAL INDEX KEY: 0001110780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 151104009
MAIL ADDRESS:
STREET 1: 161 WEST 61ST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
edgar.xml
FORM 4 -
X0306
4
2015-09-09
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001110780
GOLDFISCHER CARL
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD, SUITE 130
NEWARK
CA
94560
1
0
0
0
Common Stock
2015-09-09
4
S
0
13
2.76
D
28
I
By Bay City Capital LLC
Common Stock
2015-09-09
4
S
0
13844
2.76
D
29980
I
By The Bay City Capital Fund II, L.P.
Common Stock
2015-09-09
4
S
0
905
2.76
D
1959
I
By The Bay City Capital Fund II Co-Investment Fund, L.P
Common Stock
2015-09-10
4
S
0
15
2.71
D
13
I
By Bay City Capital LLC
Common Stock
2015-09-10
4
S
0
15474
2.71
D
14506
I
By The Bay City Capital Fund II, L.P.
Common Stock
2015-09-10
4
S
0
1011
2.71
D
948
I
By The Bay City Capital Fund II Co-Investment Fund, L.P.
Common Stock
2015-09-11
4
S
0
13
2.77
D
0
I
By Bay City Capital LLC
Common Stock
2015-09-11
4
S
0
14506
2.76
D
0
I
By The Bay City Capital Fund II, L.P.
Common Stock
2015-09-11
4
S
0
948
2.76
D
0
I
By The Bay City Capital Fund II Co-Investment Fund, L.P.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The Reporting Person is a managing director of Bay City Capital LLC, The Bay City Capital Fund II, L.P. and The Bay City Capital Fund II Co-Investment Fund, L.P (collectively the "Bay City Capital Funds"), and has voting and investment control over the shares owned by the Bay City Capital Funds. The Reporting Person disclaims beneficial ownership of the shares owned by the Bay City Capital Funds except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.66 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.69 to $2.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Sujal Shah, by power of attorney
2015-09-11